Cancer Clinical Trial
Official title:
Body-Based Complementary Therapies for Patients With Cancer
RATIONALE: Massage therapy may help relieve symptoms associated with cancer. It is not yet
known which type of massage therapy is more effective in treating the symptoms of patients
with cancer.
PURPOSE: This randomized clinical trial is studying different types of massage therapy to
compare how well they work in treating the symptoms of patients with locally advanced or
metastatic cancer.
OBJECTIVES:
- Compare the safety and tolerated dose (i.e., duration, techniques, and degree of
pressure) of professional massage therapy vs professional simple presence (no touch)
massage therapy vs usual care followed by caregiver massage therapy vs usual care in
patients with locally advanced or metastatic cancer.
- Correlate these therapies with pain, anxiety, depression, nausea, and shortness of
breath in these patients.
- Correlate these therapies with patient quality of life and caregiver anxiety and
depression.
- Determine the feasibility of teaching family caregivers how to provide massage therapy
and the subsequent use of massage by the caregivers.
- Determine the effects of caregiver massage therapy on patients and caregivers.
- Determine the feasibility and acceptability among patients and massage therapists of a
simple presence (no touch) massage therapy control group.
OUTLINE: This is a randomized, controlled, pilot study. Patients are randomized to 1 of 3
treatment arms.
- Arm I (professional massage therapy): Hospitalized patients are offered massage therapy
by a licensed massage therapist for 15-45 minutes once daily for the duration of their
hospital stay. Outpatient oncology clinic patients are offered home-based massage
therapy by a licensed massage therapist for 15-45 minutes once daily for 3 days.
- Arm II (usual care): Patients receive usual care for symptom management.
- Arm III (professional simple presence [no touch] massage therapy): Hospitalized
patients are offered simple presence (no touch) massage therapy comprising a room visit
by a licensed massage therapist who places his/her hands 12 inches over the patient
without direct touch for 15-45 minutes. Treatment is offered once daily for the
duration of the hospital stay. Outpatient oncology clinic patients are offered
home-based simple presence (no touch) massage therapy by a licensed massage therapist
for 15-45 minutes once daily for 3 days.
All patients are then randomized (a second time) to 1 of 2 treatment arms.
- Arm I (caregiver massage therapy): Previously hospitalized patients are offered
home-based caregiver massage therapy for 1 month. Outpatient oncology clinic patients
are offered home-based caregiver massage therapy for 3 weeks.
- Arm II (usual care): Patients receive usual care for symptom management. Hospitalized
patients complete a questionnaire addressing symptoms, quality of life, satisfaction
with symptom control, and time spent up or out of bed once daily on days 1-5, every 3
days while in the hospital, and then at 1 week, 2 weeks, and 1 month after discharge
from the hospital. Outpatient oncology clinic patients complete a similar telephone
questionnaire at baseline, 1 week, and then at 1 month.
PROJECTED ACCRUAL: Approximately 100 patients will be accrued for this study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|